-
1دورية أكاديمية
المؤلفون: Hayashi, Toshinobu1, Shimokawa, Mototsugu2, Matsuo, Koichi1, Uchiyama, Masanobu3, Kawada, Kei4, Nakano, Takafumi1, Egawa, Takashi1
المصدر: Oncology. Sep, Vol. 101 Issue 9, p584-590. 7p.
مصطلحات موضوعية: *VOMITING prevention, *DRUG efficacy, *RESEARCH, *CARBOPLATIN, *NAUSEA, *COMBINATION drug therapy, *SCIENTIFIC observation, *DEXAMETHASONE, *CANCER chemotherapy, *PATIENT selection, *ISOQUINOLINE, *DISEASE incidence, *TREATMENT effectiveness, *CANCER patients, *DRUG monitoring, *ANTIEMETICS, *LONGITUDINAL method, *EVALUATION
-
2دورية أكاديمية
المؤلفون: Sakai, Chizuru, Shimokawa, Mototsugu, Iihara, Hirotoshi, Fujita, Yukiyoshi, Ikemura, Shinnosuke, Hirose, Chiemi, Kotake, Mie, Funaguchi, Norihiko, Gomyo, Takenobu, Imai, Hisao, Hakamata, Jun, Kaito, Daizo, Minato, Koichi, Arai, Takahiro, Kawazoe, Hitoshi, Suzuki, Akio, Ohno, Yasushi, Okura, Hiroyuki
المصدر: Oncologist; Jun2021, Vol. 26 Issue 6, pe1066-e1072, 7p, 5 Charts, 1 Graph
مصطلحات موضوعية: CHEST tumors, DRUG efficacy, RESEARCH, CARBOPLATIN, COMBINATION drug therapy, CLINICAL trials, SEROTONIN antagonists, DEXAMETHASONE, ORAL drug administration, MEDICAL cooperation, TREATMENT effectiveness, CANCER patients, OLANZAPINE, ANTIEMETICS, LONGITUDINAL method
مصطلحات جغرافية: JAPAN
-
3دورية أكاديمية
المؤلفون: Kashiwada, Tomomi, Shinozaki, Katsunori, Ueno, Shohei, Kawanaka, Hirofumi, Uno, Futoshi, Okita, Yoshihiro, Fukahori, Masaru, Matsushita, Hidenobu, Emi, Yasunori, Shimokawa, Mototsugu, Makiyama, Akitaka, Saeki, Hiroshi, Oki, Eiji, Maehara, Yoshihiko, Mori, Masaki, Baba, Eishi
المصدر: International Journal of Clinical Oncology; 2021, Vol. 26 Issue 2, p345-354, 10p
مصطلحات موضوعية: ESOPHAGOGASTRIC junction, OXALIPLATIN, COMBINATION drug therapy, STOMACH cancer, PROGRESSION-free survival
-
4دورية أكاديمية
المؤلفون: Yuki, Satoshi, Shinozaki, Katsunori, Kashiwada, Tomomi, Kusumoto, Tetsuya, Iwatsuki, Masaaki, Satake, Hironaga, Kobayashi, Kazuma, Esaki, Taito, Nakashima, Yuichiro, Kawanaka, Hirofumi, Emi, Yasunori, Komatsu, Yoshito, Shimokawa, Mototsugu, Makiyama, Akitaka, Saeki, Hiroshi, Oki, Eiji, Baba, Hideo, Mori, Masaki
المصدر: Cancer Chemotherapy & Pharmacology; Jan2020, Vol. 85 Issue 1, p217-223, 7p
مصطلحات موضوعية: STOMACH cancer, TRASTUZUMAB, PACLITAXEL, SOCKS, PROGRESSION-free survival, CARBOPLATIN, ADVERSE health care events, THERAPEUTIC use of antineoplastic agents, STOMACH tumors, RESEARCH, LIVER tumors, COMBINATION drug therapy, CLINICAL trials, HETEROCYCLIC compounds, CANCER invasiveness, CELL receptors, CANCER relapse, METASTASIS, MEDICAL cooperation, FLUOROURACIL, LONGITUDINAL method
-
5دورية أكاديمية
المؤلفون: Ando, Koji, Emi, Yasunori, Suenaga, Toyokuni, Hamanoue, Masahiro, Maekawa, Soichiro, Sakamoto, Yasuo, Kai, Seiichiro, Satake, Hironaga, Shimose, Takayuki, Shimokawa, Mototsugu, Saeki, Hiroshi, Oki, Eiji, Sakai, Kenji, Akagi, Yoshito, Baba, Hideo, Maehara, Yoshihiko
المصدر: International Journal of Clinical Oncology; Oct2017, Vol. 22 Issue 5, p913-920, 8p
مصطلحات موضوعية: COLON cancer treatment, BEVACIZUMAB, IRINOTECAN, COMBINATION drug therapy, DRUG efficacy, DRUG toxicity, THERAPEUTICS
-
6دورية أكاديمية
المؤلفون: Takahashi, Takao, Emi, Yasunori, Oki, Eiji, Kobayashi, Kazuma, Tsuji, Akihito, Shimokawa, Mototsugu, Tanaka, Takaho, Akagi, Yoshito, Ogata, Yutaka, Baba, Hideo, Yoshida, Kazuhiro, Natsugoe, Shoji, Maehara, Yoshihiko, Kyushu Study Group of Clinical Cancer (KSCC)
المصدر: Cancer Chemotherapy & Pharmacology; Sep2016, Vol. 78 Issue 3, p585-593, 9p
مصطلحات موضوعية: RECTAL cancer treatment, COMBINATION drug therapy, CETUXIMAB, FLUOROPYRIMIDINES, OXALIPLATIN, IRINOTECAN, LABORATORY rats, THERAPEUTICS, ANTINEOPLASTIC agents, CLINICAL trials, COLON tumors, COMPARATIVE studies, FLUOROURACIL, HETEROCYCLIC compounds, RESEARCH methodology, MEDICAL cooperation, METASTASIS, PROGNOSIS, PROTEINS, RECTUM tumors, RESEARCH, SURVIVAL, TRANSFERASES, EVALUATION research, TREATMENT effectiveness
-
7دورية أكاديمية
المؤلفون: Ogata, Yutaka1 yogata@med.kurume-u.ac.jp, Shimokawa, Mototsugu2, Tanaka, Takaho3, Emi, Yasunori4, Oki, Eiji5, Saeki, Hiroshi5, Sadanaga, Noriaki4, Kusumoto, Tetsuya5, Touyama, Tetsuo6, Kimura, Masami7, Baba, Hideo8, Akagi, Yoshito9, Shirouzu, Kazuo9, Maehara, Yoshihiko5 maehara@surg2.med.kyushu-u.ac.jp
المصدر: International Journal of Clinical Oncology. Apr2016, Vol. 21 Issue 2, p335-343. 9p.
مصطلحات موضوعية: *COLON cancer patients, *COLON cancer treatment, *BEVACIZUMAB, *COMBINATION drug therapy, *JAPANESE people, *LONGITUDINAL method, *DISEASES
-
8دورية أكاديمية
المؤلفون: Kurozumi, Akira1 (AUTHOR) akira@med.uoeh-u.ac.jp, Okada, Yosuke1 (AUTHOR), Shimokawa, Mototsugu2 (AUTHOR), Goshima, Yukiko1 (AUTHOR), Otsuka, Takashi1 (AUTHOR), Narisawa, Manabu1 (AUTHOR), Torimoto, Keiichi1 (AUTHOR), Tanaka, Yoshiya1 (AUTHOR)
المصدر: Diabetes Technology & Therapeutics. Jul2019, Vol. 21 Issue 7, p385-392. 8p.
مصطلحات موضوعية: *SODIUM-glucose cotransporters, *DAPAGLIFLOZIN, *TYPE 2 diabetes, *GLUCOSE, *BENZENE, *SULFUR compounds, *RESEARCH, *COMBINATION drug therapy, *BLOOD sugar monitoring, *RESEARCH methodology, *BLOOD sugar, *GLYCOSIDES, *HYPOGLYCEMIC agents, *EVALUATION research, *MEDICAL cooperation, *TREATMENT effectiveness, *INSULIN, *COMPARATIVE studies, *CROSSOVER trials
-
9دورية أكاديمية
المؤلفون: Takada, Kazuki1 (AUTHOR), Buti, Sebastiano1,2,3 (AUTHOR), Bersanelli, Melissa3 (AUTHOR), Shimokawa, Mototsugu4,5 (AUTHOR), Takamori, Shinkichi6 (AUTHOR), Matsubara, Taichi7 (AUTHOR), Takenaka, Tomoyoshi8 (AUTHOR), Okamoto, Tatsuro6 (AUTHOR), Hamatake, Motoharu7 (AUTHOR), Tsuchiya-Kawano, Yuko9 (AUTHOR), Otsubo, Kohei9 (AUTHOR), Nakanishi, Yoichi9 (AUTHOR), Okamoto, Isamu10 (AUTHOR), Pinato, David J.11,12 (AUTHOR), Cortellini, Alessio1,11 (AUTHOR) a.cortellini@imperial.ac.uk, Yoshizumi, Tomoharu1,8 (AUTHOR)
المصدر: European Journal of Cancer. Sep2022, Vol. 172, p199-208. 10p.
مصطلحات موضوعية: *LUNG cancer prognosis, *THERAPEUTIC use of probiotics, *ANTIBIOTICS, *LUNG cancer, *COMBINATION drug therapy, *IMMUNE checkpoint inhibitors, *ADRENOCORTICAL hormones, *CONFIDENCE intervals, *LOG-rank test, *DRUG-food interactions, *PROTON pump inhibitors, *RISK assessment, *SURVIVAL analysis (Biometry), *PROGRESSION-free survival, *LONGITUDINAL method, *EVALUATION